NCT05236179

Brief Summary

Observational study of general patient satisfaction and inpatients' experiences with integrative therapies. The study recruits inpatients of the Filderklinik, an anthroposophic hospital in southwestern Germany. The aim is to assess overall patient satisfaction and inpatients' experiences with integrative therapies at the Filderklinik.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 11, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

February 15, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2022

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

11 months

First QC Date

February 2, 2022

Last Update Submit

April 18, 2023

Conditions

Keywords

Integrative therapiesAnthroposophic medicineOverall patient satisfactionInpatientsSurvey

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction, ZUF-8 total score

    Patient satisfaction, measured with the ZUF-8 patient satisfaction questionnaire, a validated questionnaire (German language) with 8 items related to overall patient satisfaction associated with an inpatient hospital stay. Items are rated on 4-point scales from positive to negative (no "neutral" position), with 1 being the least positive and 4 being the most positive value (total scale range 8-32). In the current study, the ZUF-8 is part of the comprehensive "Special Therapy Procedures" questionnaire, which covers all outcome measures not retrieved from the clinic database.

    Assessing the entire duration of the hospital stay, an average of 7 days.

Secondary Outcomes (17)

  • Diagnoses

    Assessing the entire duration of the hospital stay, an average of 7 days.

  • Therapies

    Assessing the entire duration of the hospital stay, an average of 7 days.

  • OPS codings

    Assessing the entire duration of the hospital stay, an average of 7 days.

  • Inpatient admitting department

    At the time of admission to the Filderklinik, at the beginning of hospitalization (an average of 7 days).

  • Integrative therapies according to clinic database

    Assessing the entire duration of the hospital stay, an average of 7 days.

  • +12 more secondary outcomes

Interventions

Integrative therapy methods used at the Filderklinik, such as music therapy, therapeutic painting, therapeutic sculptural forming, speech therapy, eurythmy therapy, rhythmical massage, external applications, coloured light therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inpatients of the Filderklinik who have received at least 10 treatments with one or more of the various integrative therapy methods used at the Filderklinik.

You may qualify if:

  • Written informed consent
  • Filderklinik inpatient who had at least 10 treatments with one ore more of the integrative therapy methods
  • Age 18 years or older

You may not qualify if:

  • Insufficient German language skills
  • Legally incapacitated patients
  • Patients who are physically incapable of giving written consent
  • Patients in isolation wards

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arcim Institute

Filderstadt, Baden-Wurttemberg, 70794, Germany

Location

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Jan Vagedes, Dr

    ARCIM Institute Academic Research in Complementary and Integrative Medicine

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2022

First Posted

February 11, 2022

Study Start

February 15, 2022

Primary Completion

December 29, 2022

Study Completion

December 29, 2022

Last Updated

April 19, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
The data will be made available upon publication for a duration of three months.
Access Criteria
The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.

Locations